Insights

Research Collaborations VHIO actively partners with leading pharmaceutical companies like Roche and AstraZeneca, demonstrating openness to collaborative research and clinical trials. This presents opportunities to offer targeted diagnostics, innovative therapies, or data management solutions aligned with their ongoing projects.

Focus on Precision Oncology With a clear emphasis on personalized medicine and precision oncology, VHIO is likely investing in advanced genetic testing, biomarker identification, and targeted treatment platforms, which can be potential sales avenues for genomics tools, diagnostic technologies, and related software.

Active Scientific Engagement VHIO's involvement in international congresses and research networks like ECRIN highlights their commitment to cutting-edge translational research, opening opportunities to provide advanced research equipment, data analytics, or clinical trial management services.

Funding and Innovation Programs The launch of the VHIO-AstraZeneca Disruption Program indicates a strategic focus on innovation and technology development, suggesting a readiness to partner on novel therapeutic platforms, drug discovery tools, and innovative treatment delivery systems.

Growing Institutional Network As part of a multidisciplinary healthcare environment within Vall d'Hebron Hospital, VHIO’s broad network of clinical and research professionals could facilitate the sale of integrated solutions such as patient data systems, research management platforms, or cross-institutional collaboration tools.

Vall d'Hebron Institute of Oncology (VHIO) Tech Stack

Vall d'Hebron Institute of Oncology (VHIO) uses 8 technology products and services including Fusion Ads, AutoCAD, MySQL, and more. Explore Vall d'Hebron Institute of Oncology (VHIO)'s tech stack below.

  • Fusion Ads
    Advertising
  • AutoCAD
    Cad & Graphics
  • MySQL
    Database
  • WooCommerce
    E-commerce
  • Microsoft PowerPoint
    Editors
  • OpenAI
    Generative Ai
  • Bash
    Operating Systems & Computing Languages
  • Microsoft Azure
    Platform As A Service

Media & News

Vall d'Hebron Institute of Oncology (VHIO)'s Email Address Formats

Vall d'Hebron Institute of Oncology (VHIO) uses at least 1 format(s):
Vall d'Hebron Institute of Oncology (VHIO) Email FormatsExamplePercentage
FLast@vhio.netJDoe@vhio.net
97%
LFirst@vhio.netDJohn@vhio.net
2%
FL@vhio.netJD@vhio.net
1%

Frequently Asked Questions

Where is Vall d'Hebron Institute of Oncology (VHIO)'s headquarters located?

Minus sign iconPlus sign icon
Vall d'Hebron Institute of Oncology (VHIO)'s main headquarters is located at Spain. The company has employees across 4 continents, including EuropeSouth AmericaAsia.

What is Vall d'Hebron Institute of Oncology (VHIO)'s official website and social media links?

Minus sign iconPlus sign icon
Vall d'Hebron Institute of Oncology (VHIO)'s official website is vhio.net and has social profiles on LinkedIn.

What is Vall d'Hebron Institute of Oncology (VHIO)'s NAICS code?

Minus sign iconPlus sign icon
Vall d'Hebron Institute of Oncology (VHIO)'s NAICS code is 5417 - Scientific Research and Development Services.

How many employees does Vall d'Hebron Institute of Oncology (VHIO) have currently?

Minus sign iconPlus sign icon
As of June 2026, Vall d'Hebron Institute of Oncology (VHIO) has approximately 798 employees across 4 continents, including EuropeSouth AmericaAsia. Key team members include Chief Scientific Officer: A. P. G.Head Photographer: K. W.Head Molecular Oncology Group: P. N.. Explore Vall d'Hebron Institute of Oncology (VHIO)'s employee directory with LeadIQ.

What industry does Vall d'Hebron Institute of Oncology (VHIO) belong to?

Minus sign iconPlus sign icon
Vall d'Hebron Institute of Oncology (VHIO) operates in the Research Services industry.

What technology does Vall d'Hebron Institute of Oncology (VHIO) use?

Minus sign iconPlus sign icon
Vall d'Hebron Institute of Oncology (VHIO)'s tech stack includes Fusion AdsAutoCADMySQLWooCommerceMicrosoft PowerPointOpenAIBashMicrosoft Azure.

What is Vall d'Hebron Institute of Oncology (VHIO)'s email format?

Minus sign iconPlus sign icon
Vall d'Hebron Institute of Oncology (VHIO)'s email format typically follows the pattern of FLast@vhio.net. Find more Vall d'Hebron Institute of Oncology (VHIO) email formats with LeadIQ.

When was Vall d'Hebron Institute of Oncology (VHIO) founded?

Minus sign iconPlus sign icon
Vall d'Hebron Institute of Oncology (VHIO) was founded in 2006.
Vall d'Hebron Institute of Oncology (VHIO) logo

Vall d'Hebron Institute of Oncology (VHIO)

Research ServicesSpain501-1000 Employees

The Vall d’Hebron Institute of Oncology (VHIO) is a Spain-based cancer research center that operates within the Vall d’Hebron Barcelona Hospital Campus. Under the leadership of Josep Tabernero, VHIO pursues translational and clinical research aimed at advancing precision oncology and addressing the complexities of cancer, including resistance and metastasis. The organization emphasizes collaboration with physician-scientists at Vall d’Hebron University Hospital to integrate bench‑side and bedside insights, enabling direct access to patients and rapid translation of findings into practice. VHIO collaborates through cross-border programs and partnerships to broaden its research scope, including joint initiatives with industry and international networks, and has engaged in multiple recent activities such as presenting advances at genetics congresses and participating in first-in-human studies with industry partners. The center serves the broader oncology research community and patients by focusing on innovative, targeted approaches to cancer care and by fostering interdisciplinary, translational science within a multidisciplinary framework.

Section iconCompany Overview

Headquarters
Spain
Website
vhio.net
NAICS Code
5417 - Scientific Research and Development Services
Founded
2006
Employees
501-1000

Section iconFunding & Financials

  • $25M$50M

    Vall d'Hebron Institute of Oncology (VHIO)'s revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    Vall d'Hebron Institute of Oncology (VHIO)'s revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.